Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Vomiting; This is a spontaneous report from a contactable physician. This is a report received from the regulatory authority. Regulatory authority report number GB-MHRA-WEBCOVID-20201230095817, Sender''s Safety Report Unique Identifier GB-MHRA-ADR 24548721. A 89-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot/Batch number EI0553), via an unspecified route of administration on 17Dec2020 at single dose for COVID-19 immunization. Medical history included metastatic neoplasm (from CA lung), myocardial ischaemia (IHD) and type 2 diabetes mellitus (NIDDM) from unknown dates and unknown if ongoing and chronic lymphocytic leukaemia from 2019. Concomitant medication included amlodipine for IHD, atorvastatin for IHD, isosorbide mononitrate (MONOMIL XL) for IHD, omeprazole for hyperacidity, morphine sulfate pentahydrate (ORAMORPH) for palliative care, prednisone for palliative care, influenza vaccine (INFLUENZA VACCINE SEQIRUS) on 10Oct2020 for immunization, ticagrelor for IHD and steroids at 65 mg. The patient experienced vomiting on 18Dec2020, which was fatal. This man was terminally ill but commenced vomiting approximately 12 hours after vaccine administration. This vomiting continued for three days until his death. The patient died on 21Dec2020 due to vomiting. It was not reported if an autopsy was performed. Patient has not tested positive for Coronavirus disease 2019 since having the vaccine. Patient has not had symptoms associated with Coronavirus disease 2019. Patient has not been tested/or has had an inconclusive test for Coronavirus disease 2019. Patient is not enrolled in clinical trial. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Vomiting
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166